Acambis PLC - Earning & Dividend Analysis Snapshot

This detailed Report provides an Earnings and Dividends history for Acambis PLC. Tabular results include up to a ten-year history of "as reported" Earnings per Share and Dividends per Share plus a calculation of the amount of earnings paid out over the year in dividends (i.e. Payout Ratio). Earnings and Dividends are presented on both a Quarterly and Annual basis. An annual Percent Change factor is calculated for both Earnings and Dividends.

Acambis PLC. The Group's principal activity is researching, developing and manufacturing vaccines to prevent and treat infectious diseases. The Group's vaccine product are ChimeriVax-JE and ChimeriVax-West Nile. ChimeriVax-JE is a single-dose vaccine for travellers and those living in endemic regions. ChimeriVax-West Nile focuses on viruses transmitted to humans and animals by the bite of an infected mosquito. The Group's other pipeline products are Clostridium difficile and Influenza vaccine. The Group operates in the United Kingdom and the United States of America.

Not the Report you are looking for? Click here for more browsing options.

view sample Single Report

view sample All Basic Reports

Layout and Content of a Typical Report